Pakola Steve
Chief Medical Officer at RGNX
- Sold, on record
- $1.7M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Jul 2, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- RGNXREGENXBIO Inc.Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice RGNXNoticeJan 3, 2024 2024
Filed to sell 17,237 shares ($316k)
Pakola Steve, Officer
10b5-1 planFiling
- 2 Form 4 sale RGNXRoutineJan 3, 2024 same day
Sold 17,237 shares at $17.39 ($300k)
Pakola Steve, Chief Medical Officer
10b5-1 planSold 13.9% of holdings ($2.2M position)107,192 shares leftFollows a Form 144Filing
- 3 Form 144 notice RGNXNoticeMar 5, 2024 +62 days
Filed to sell 12,878 shares ($275k)
Pakola Steve, Officer
10b5-1 planFiling
- 4 Form 4 sale RGNXRoutineMar 5, 2024 same day
Sold 12,878 shares at $28.36 ($365k)
Pakola Steve, Chief Medical Officer
10b5-1 planSold 10.7% of holdings ($3.4M position)107,192 shares leftFollows a Form 144Filing
- 5 Form 4 sale RGNXRoutineMar 10, 2026 +735 days
Sold 5,124 shares at $10.35 ($53k)
Pakola Steve, Chief Medical Officer
10b5-1 planSold 2% of holdings ($2.6M position)247,926 shares leftFirst sale on recordFiling
- 6 Form 4 sale RGNXRoutineMay 11, 2026 +62 days
Sold 15,309 shares at $11.02 ($169k)
Pakola Steve, Chief Medical Officer
10b5-1 planSold 6.2% of holdings ($2.7M position)232,617 shares leftFiling
- 7 Form 4 sale RGNXNo planJul 1, 2026 +51 days
Sold 56,333 shares at $12.23 ($689k)
Pakola Steve, Chief Medical Officer
No 10b5-1 planSold 20.9% of holdings ($3.3M position)213,009 shares leftFiling
- 8 Form 4 sale RGNXRoutineJul 2, 2026 +1 day
Sold 2,161 shares at $13.64 ($29k)
Pakola Steve, Chief Medical Officer
10b5-1 planSold 1% of holdings ($2.9M position)213,009 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Jul 6, 2026 | RGNX | Chief Medical Officer | Form 4 sale | 2,161 | $29k | 1.0% | Routine | SEC |
| Jul 1, 2026 | Jul 1, 2026 | RGNX | Chief Medical Officer | Form 4 sale | 56,333 | $689k | 20.9% | No plan | SEC |
| May 11, 2026 | May 13, 2026 | RGNX | Chief Medical Officer | Form 4 sale | 15,309 | $169k | 6.2% | Routine | SEC |
| Mar 10, 2026 | Mar 12, 2026 | RGNX | Chief Medical Officer | Form 4 sale | 5,124 | $53k | 2.0% | Routine | SEC |
| Mar 5, 2024 | Mar 7, 2024 | RGNX | Chief Medical Officer | Form 4 sale | 12,878 | $365k | 10.7% | Routine | SEC |
| Mar 5, 2024 | Mar 5, 2024 | RGNX | Officer | Form 144 notice | 12,878 | $275k | Notice | SEC | |
| Jan 3, 2024 | Jan 4, 2024 | RGNX | Chief Medical Officer | Form 4 sale | 17,237 | $300k | 13.9% | Routine | SEC |
| Jan 3, 2024 | Jan 3, 2024 | RGNX | Officer | Form 144 notice | 17,237 | $316k | Notice | SEC | |
| Jan 3, 2023 | Jan 5, 2023 | RGNX | Chief Medical Officer | Form 4 sale | 3,138 | $70k | 20.5% | Plan not stated | SEC |
| Jan 3, 2022 | Jan 4, 2022 | RGNX | Chief Medical Officer | Form 4 sale | 1,598 | $54k | 16.2% | Plan not stated | SEC |